STOCK TITAN

ICON Announces Appointment of New Chief Financial Officer

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management

ICON plc (NASDAQ: ICLR) has announced the appointment of Nigel Clerkin as its new Chief Financial Officer (CFO). Clerkin brings extensive experience from his previous roles, including CFO positions at Elan , ConvaTec, UDG Healthcare, and LetsGetChecked. He will join ICON early in Q4 2023, based in the Dublin office.

Clerkin holds a BSc and Master's in Accounting from Queen's University Belfast and is a qualified chartered accountant. ICON's CEO, Steve Cutler, expressed confidence in Clerkin's ability to bring valuable insights to the role as ICON continues to grow. Clerkin replaces outgoing CFO Brendan Brennan, who has served the company for 18 years.

ICON plc (NASDAQ: ICLR) ha annunciato la nomina di Nigel Clerkin come nuovo Direttore Finanziario (CFO). Clerkin porta con sé una vasta esperienza dai suoi ruoli precedenti, tra cui quelli di CFO presso Elan, ConvaTec, UDG Healthcare e LetsGetChecked. Inizierà a lavorare per ICON all'inizio del quarto trimestre 2023, basandosi nell'ufficio di Dublino.

Clerkin possiede una laurea e un master in Accounting presso la Queen's University Belfast ed è un commercialista autorizzato. Il CEO di ICON, Steve Cutler, ha espresso fiducia nella capacità di Clerkin di fornire preziose intuizioni nel ruolo mentre ICON continua a crescere. Clerkin sostituisce l'ex CFO Brendan Brennan, che ha servito l'azienda per 18 anni.

ICON plc (NASDAQ: ICLR) ha anunciado la designación de Nigel Clerkin como su nuevo Director Financiero (CFO). Clerkin aporta una amplia experiencia de sus roles anteriores, incluidos los cargos de CFO en Elan, ConvaTec, UDG Healthcare y LetsGetChecked. Se unirá a ICON a principios del cuarto trimestre de 2023, con sede en la oficina de Dublín.

Clerkin tiene una licenciatura y un máster en Contabilidad de la Queen's University Belfast y es un contable profesional calificado. El CEO de ICON, Steve Cutler, expresó confianza en la capacidad de Clerkin para aportar valiosas perspectivas al rol mientras ICON continúa creciendo. Clerkin reemplaza al saliente CFO Brendan Brennan, quien ha estado en la empresa durante 18 años.

ICON plc (NASDAQ: ICLR)는 Nigel Clerkin을 새로운 최고재무책임자(CFO)로 임명했다고 발표했습니다. Clerkin은 Elan, ConvaTec, UDG Healthcare, LetsGetChecked에서 CFO 직책을 포함하여 이전 역할에서 광범위한 경험을 가지고 있습니다. 그는 2023년 4분기 초 더블린 사무소에서 ICON에 합류할 예정입니다.

Clerkin은 퀸즈 대학교 벨파스트에서 회계학 학사 및 석사 학위를 보유하고 있으며, 자격을 갖춘 공인회계사입니다. ICON의 CEO인 Steve Cutler는 ICON이 계속 성장하는 가운데 Clerkin이 이 역할에 귀중한 통찰력을 가져다줄 것이라는 확신을 표명했습니다. Clerkin은 18년간 회사를 위해 봉사한 퇴임 CFO Brendan Brennan을 대신하게 됩니다.

ICON plc (NASDAQ: ICLR) a annoncé la nomination de Nigel Clerkin en tant que nouveau Directeur Financier (CFO). Clerkin apporte une vaste expérience de ses précédents postes, y compris ceux de CFO chez Elan, ConvaTec, UDG Healthcare et LetsGetChecked. Il rejoindra ICON début du quatrième trimestre 2023, basé au bureau de Dublin.

Clerkin détient une licence et un master en comptabilité de la Queen's University Belfast et est un expert-comptable qualifié. Le PDG d'ICON, Steve Cutler, a exprimé sa confiance dans la capacité de Clerkin à apporter des idées précieuses au rôle, tandis qu'ICON continue de croître. Clerkin remplace l'ancien CFO Brendan Brennan, qui a servi l'entreprise pendant 18 ans.

ICON plc (NASDAQ: ICLR) hat die Ernennung von Nigel Clerkin zum neuen Chief Financial Officer (CFO) bekannt gegeben. Clerkin bringt umfangreiche Erfahrungen aus seinen vorherigen Positionen mit, darunter CFO-Rollen bei Elan, ConvaTec, UDG Healthcare und LetsGetChecked. Er wird Anfang des vierten Quartals 2023 bei ICON beginnen und in dem Büro in Dublin arbeiten.

Clerkin hat einen Bachelor- und einen Master-Abschluss in Buchhaltung von der Queen's University Belfast und ist ein qualifizierter Wirtschaftsprüfer. ICON-CEO Steve Cutler äußerte Vertrauen in Clerkins Fähigkeit, wertvolle Einblicke in die Rolle zu bringen, da ICON weiterhin wächst. Clerkin ersetzt den scheidenden CFO Brendan Brennan, der 18 Jahre lang für das Unternehmen tätig war.

Positive
  • Appointment of experienced CFO with extensive background in life sciences and healthcare services
  • New CFO has strong track record of supporting financial growth in large organizations
  • Incoming CFO has significant experience in M&A and financial systems enhancement
Negative
  • None.

DUBLIN--(BUSINESS WIRE)-- ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced the appointment of Nigel Clerkin as its new Chief Financial Officer (CFO).

Nigel brings extensive experience and capability to the role of CFO. He commenced his career with KPMG, before joining Elan Corporation where he held a number of roles of increasing responsibility over a fifteen-year career, culminating in the role of group CFO in 2011, which he held until 2014. Nigel then moved to be CFO at ConvaTec, a global medical and technologies company, before becoming UDG Healthcare’s CFO in 2018. During his tenure with UDG, he led substantial change and improvement programmes and oversaw strong financial growth across multiple business lines. Most recently, Nigel was CFO at LetsGetChecked, a global provider of at-home healthcare services.

Nigel has a long tenure and a strong track record of success as CFO in a number of large organisations in the life sciences and healthcare services industry. He has successfully led and supported the financial growth of a number of organisations and has a strong background as a CFO of a public company with significant experience in M&A as well as financial processes and systems enhancement.

Nigel holds a Bachelor of Science (Accounting) degree and a Master of Accounting degree from Queen’s University Belfast and is also a qualified chartered accountant and a fellow of Chartered Accountants Ireland.

Nigel will be based in ICON’s Dublin office and will join ICON early in quarter four this year.

“I am pleased to announce Nigel’s appointment as ICON’s next CFO,” said Steve Cutler, ICON’s CEO. “His vast experience as a CFO across a number of life science and healthcare service organisations will bring valuable experience, insights and new perspectives to the role. I look forward to working with Nigel in the years ahead as ICON continues to grow and become the healthcare intelligence partner of choice for all of our customers. Finally, I would also like to thank our outgoing CFO, Brendan Brennan, for his significant contribution to ICON over the past 18 years and wish him further success in the future.”

“It is a privilege to have been selected to be ICON’s next CFO,” said Nigel Clerkin. “ICON is a company I have long admired and respected and I have been continuously impressed with the company’s performance and continuing growth as a market leader within the CRO industry. I look forward to working with the ICON Executive team and working closely with the strong talent across the organisation particularly within the finance team, to continue ICON’s growth and success into the future.”

About ICON plc

ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,100 employees in 97 locations in 55 countries as at June 30, 2024. For further information about ICON, visit: www.iconplc.com.

This press release contains forward-looking statements, including statements about our financial guidance. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.

ICON/ICLR-F

Kate Haven

Vice President Investor Relations

+1 888 381 7923

Source: ICON plc

FAQ

Who is the new CFO of ICON plc (ICLR)?

Nigel Clerkin has been appointed as the new Chief Financial Officer of ICON plc (NASDAQ: ICLR).

When will Nigel Clerkin join ICON as CFO?

Nigel Clerkin will join ICON early in the fourth quarter of 2023.

What is Nigel Clerkin's professional background?

Nigel Clerkin has previously held CFO positions at Elan , ConvaTec, UDG Healthcare, and LetsGetChecked, with extensive experience in the life sciences and healthcare services industry.

Where will ICON's new CFO Nigel Clerkin be based?

Nigel Clerkin will be based in ICON's Dublin office.

Icon Plc

NASDAQ:ICLR

ICLR Rankings

ICLR Latest News

ICLR Stock Data

24.76B
82.82M
0.65%
99.71%
1.99%
Diagnostics & Research
Healthcare
Link
United States of America
Dublin